Gab1 Overexpression Attenuates Susceptibility to Ventricular Arrhythmias in Pressure Overloaded Heart Failure Mouse Hearts
- PMID: 36374360
- DOI: 10.1007/s10557-022-07394-0
Gab1 Overexpression Attenuates Susceptibility to Ventricular Arrhythmias in Pressure Overloaded Heart Failure Mouse Hearts
Abstract
Purpose: Grb2 associated binding protein 1 (Gab1) is an adaptor protein that is important for intracellular signal transduction which involved in several pathological process. However, the role of Gab1 in pressure overload-induced ventricular arrhythmias (VAs) remain poorly understood. In the current study, we aimed to test the role of Gab1 in VA susceptibility induced by pressure overload.
Methods: We overexpressed Gab1 in the hearts using an adeno-associated virus 9 (AAV9) system through tail vein injection. Aortic banding (AB) surgery was performed in C57BL6/J mice to induce heart failure (HF). Four weeks following AB, histology, echocardiography, and biochemical analysis were conducted to investigate cardiac structural remodeling and electrophysiological studies were performed to check the electrical remodeling. Western blot analysis was used to explore the underlying mechanisms.
Results: The mRNA and protein expression were downregulated in AB hearts compared to sham hearts. Gab1 overexpression significantly reversed AB-induced cardiac structural remodeling including ameliorated AB-induced cardiac dysfunction, cardiac fibrosis, and inflammatory response. Moreover, Gab1 overexpression also markedly alleviated AB-induced electrical remodeling including ion channel alterations and VA susceptibility. Mechanistically, we found that TLR4/MyD88/NF-κB contributes to the cardio protective effect of Gab1 overexpression on AB-induced VAs.
Conclusions: Our study manifested that Gab1 may serve as a promising anti-arrhythmic target via inhibiting TLR4/MyD88/NF-κB signaling pathway induced by AB.
Keywords: Gab1; Heart failure; Inflammation; Pressure overload; Ventricular arrhythmia.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice.J Nutr Biochem. 2020 Apr;78:108341. doi: 10.1016/j.jnutbio.2020.108341. Epub 2020 Jan 9. J Nutr Biochem. 2020. PMID: 32004931
-
USP38 exacerbates pressure overload-induced left ventricular electrical remodeling.Mol Med. 2024 Jun 27;30(1):97. doi: 10.1186/s10020-024-00846-3. Mol Med. 2024. PMID: 38937697 Free PMC article.
-
GAB1 alleviates septic lung injury by inhibiting the TLR4/ NF-κB pathway.Clin Exp Pharmacol Physiol. 2022 Jan;49(1):94-103. doi: 10.1111/1440-1681.13589. Epub 2021 Sep 23. Clin Exp Pharmacol Physiol. 2022. PMID: 34498273
-
Loss of MD1 increases vulnerability to ventricular arrhythmia in diet-induced obesity mice via enhanced activation of the TLR4/MyD88/CaMKII signaling pathway.Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):991-998. doi: 10.1016/j.numecd.2019.06.004. Epub 2019 Jun 20. Nutr Metab Cardiovasc Dis. 2019. PMID: 31353205
-
Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1525-H1537. doi: 10.1152/ajpheart.00097.2020. Epub 2020 May 8. Am J Physiol Heart Circ Physiol. 2020. PMID: 32383996
Cited by
-
Gab1 in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area.Cardiovasc Drugs Ther. 2024 Nov 4. doi: 10.1007/s10557-024-07638-1. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 39495378 No abstract available.
References
-
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876–94. - PubMed
-
- Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91–220. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous